USANA Health Sciences
(NYSE) USNA
USANA Health Sciences Financials at a Glance
Market Cap
$347.84M
Revenue (TTM)
$925.94M
Net Income (TTM)
$8.87M
EPS (TTM)
$0.48
P/E Ratio
39.63
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$18.60
Volume
37,067.492
Open
$18.75
Price
$18.60
Volume
37,067.492
Open
$18.75
Previous Close
$18.84
Daily Range
$18.51 - $18.85
52-Week Range
$16.60 - $38.32
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$18.60
Volume
37,067.492
Open
$18.75
Previous Close
$18.84
Daily Range
$18.51 - $18.85
52-Week Range
$16.60 - $38.32
USNA News
USNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout USANA Health Sciences
Industry
Personal Products
Sector
Consumer StaplesEmployees
1,570
CEO
Kevin G. Guest
Website
www.usana.comHeadquarters
Salt Lake City, UT 84120, US
USNA Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
5%
Net Income Margin
1%
Return on Equity
2%
Return on Capital
8%
Return on Assets
1%
Earnings Yield
2.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$347.84M
Shares Outstanding
18.46M
Volume
37.07K
Avg. Volume
127.56K
Financials (TTM)
Gross Profit
$724.41M
Operating Income
$50.86M
EBITDA
$82.07M
Operating Cash Flow
$22.35M
Capital Expenditure
-$13.82M
Free Cash Flow
$8.53M
Cash & ST Invst.
$158.38M
Total Debt
$14.00M
USANA Health Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$250.22M
+0.3%
Gross Profit
$190.78M
+1.1%
Gross Margin
76.25%
N/A
Market Cap
$347.84M
N/A
Market Cap/Employee
$204.61K
N/A
Employees
1,700
N/A
Net Income
$7.52M
-20.1%
EBITDA
$23.66M
-13.6%
Quarterly Fundamentals
Net Cash
$148.75M
-5.0%
Accounts Receivable
$9.66M
N/A
Inventory
$96.36M
+31.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$14.00M
-39.1%
Return on Assets
1.20%
N/A
Return on Invested Capital
7.89%
N/A
Free Cash Flow
$7.11M
-43.9%
Operating Cash Flow
$9.76M
-37.0%